2025 Annual Meeting | H43 - Coffee Connect—Women Researchers (Research Hub)
Program Materials Program Evaluations
| 08:00 AM - 08:45 AM PDT | Discussion |
Coffee Connect—Women Researchers
Neha Dangayach, MD, FAAN, Shibani S. Mukerji, MD, PhD, Alissa A. Thomas, MD, FAAN |
| Neha Dangayach, MD, FAAN | Dr. Dangayach has nothing to disclose. |
| Shibani S. Mukerji, MD, PhD | Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has or had stock in Gilead Science.Dr. Mukerji has or had stock in Ranpack.Dr. Mukerji has or had stock in Snowflake. An immediate family member of Dr. Mukerji has or had stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital. |
| Alissa A. Thomas, MD, FAAN | The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals. |